Home » Topics » BioWorld Science

BioWorld Science
RSS

Trial starts enrollment to assess LY-3361237 in patients with psoriasis

Aug. 16, 2021

Phase I trial begins for DVX-201 allogeneic NK cells in COVID-19 patients

Aug. 16, 2021

Polymer-mediated "immunocloaking" - A new paradigm for combating transplant rejection?

Aug. 16, 2021

SARS-CoV-2 spike ectodomain protein StriFK vaccine with adjuvant reduces transmission in animals

Aug. 13, 2021

Phase I/II study of ChulaCov19 vaccine initiates at Chulalongkorn University

Aug. 13, 2021

Moderna initiates phase I/II study of mRNA-3705 in methylmalonic acidemia

Aug. 13, 2021

Nimbus and Schrödinger extend drug discovery collaboration

Aug. 13, 2021

Cogent initiates phase II study of CGT-9486 in systemic mastocytosis

Aug. 13, 2021

Sen-Jam and Duke-NUS Medical School partner to develop novel COVID-19 therapy

Aug. 13, 2021

Mustang Bio and Mayo Clinic collaborate on development of novel CAR T technology

Aug. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...